Literature DB >> 9358428

Physicochemical characterization of psychosine by 1H nuclear magnetic resonance and electron microscopy.

L Orfi1, C K Larive, S M LeVine.   

Abstract

Krabbe's disease is an autosomal recessive disease that affects the lysosomal enzyme galactosylceramidase. The storage of one of its substrates, psychosine (beta-galactosyl-sphingosine), is thought to be responsible for the induction of pathological changes. Psychosine has a free amine group which is necessary for the mediation of its toxic effects. In the present study, the physicochemical properties of psychosine were investigated. Nuclear magnetic resonance (NMR) detected pH titration was used to determine that the amine group had a pKa of 7.18 +/- 0.05. Pulsed-field gradient NMR spectroscopy was used to determine that the diffusion coefficient of 2.8 mM psychosine in D2O at pD 4.46 or 7.04 is 1.16 +/- 0.02 x 10(-10) m2/s or 0.77 +/- 0.02 x 10(-10) m2/s, respectively. Negative staining electron microscopy (EM) studies of acidic and neutral solutions of psychosine also were performed. At pH 4.5, spherical structures were formed, which were relatively stable between 3, 120, and 216 h following preparation; the diameter ranged from approximately 14 nm at the earliest time point to approximately 18 nm at the last time point. The critical micelle concentration (CMC) was 1.26 mM at pH 4.0. At pH 7.1, the structures changed from spherical structures with a diameter of 15-23 nm, at the earliest time point, to a heterogeneous population of structures ranging from spherical structures, with a diameter of only a few nm, to irregularly shaped oblong structures that had one or more dimensions exceeding 100 nm. The NMR and EM data indicate that the deprotonation of the amine group causes psychosine to form aggregates that are unstable, which prevents a determination of the CMC at a neutral pH. These data indicate that molecular interactions of psychosine at the acidic pH of the lysosome, where it is normally digested, are more orderly than those at the pH of the cytoplasm or extracellular space where psychosine goes during disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9358428     DOI: 10.1007/s11745-997-0133-x

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  17 in total

1.  PHYSIOLOGICAL ACTIVITY OF PSYCHOSINE.

Authors:  T TAKETOMI; K NISHIMURA
Journal:  Jpn J Exp Med       Date:  1964-10

2.  Inhibition of cytochrome c oxidase by psychosine (galactosylsphingosine).

Authors:  H Igisu; M Nakamura
Journal:  Biochem Biophys Res Commun       Date:  1986-05-29       Impact factor: 3.575

3.  Measurement of translational motion by pulse-gradient spin-echo nuclear magnetic resonance.

Authors:  R L Haner; T Schleich
Journal:  Methods Enzymol       Date:  1989       Impact factor: 1.600

4.  Phosphorylation of myelin basic protein in intact oligodendrocytes: inhibition by galactosylsphingosine and cyclic AMP.

Authors:  T Vartanian; G Dawson; B Soliven; D J Nelson; S Szuchet
Journal:  Glia       Date:  1989       Impact factor: 7.452

5.  Chemical pathology of Krabbe's disease. III. Ceramide-hexosides and gangliosides of brain.

Authors:  M T Vanier; L Svennerholm
Journal:  Acta Paediatr Scand       Date:  1975-07

6.  High-resolution proton NMR studies of gangliosides. 2. Use of two-dimensional nuclear Overhauser effect spectroscopy and sialylation shifts for determination of oligosaccharide sequence and linkage sites.

Authors:  T A Koerner; J H Prestegard; P C Demou; R K Yu
Journal:  Biochemistry       Date:  1983-05-24       Impact factor: 3.162

7.  Effects of psychosine (galactosylsphingosine) on the survival and the fine structure of cultured Schwann cells.

Authors:  K Tanaka; H D Webster
Journal:  J Neuropathol Exp Neurol       Date:  1993-09       Impact factor: 3.685

8.  Globoid cell leukodystrophy: additional deficiency of psychosine galactosidase.

Authors:  T Miyatake; K Suzuki
Journal:  Biochem Biophys Res Commun       Date:  1972-08-07       Impact factor: 3.575

9.  Structural requirements for long-chain (sphingoid) base inhibition of protein kinase C in vitro and for the cellular effects of these compounds.

Authors:  A H Merrill; S Nimkar; D Menaldino; Y A Hannun; C Loomis; R M Bell; S R Tyagi; J D Lambeth; V L Stevens; R Hunter
Journal:  Biochemistry       Date:  1989-04-18       Impact factor: 3.162

10.  Cerebrosides and psychosine disrupt mitochondrial functions.

Authors:  P Strasberg
Journal:  Biochem Cell Biol       Date:  1986-05       Impact factor: 3.626

View more
  3 in total

1.  Lysosomal Re-acidification Prevents Lysosphingolipid-Induced Lysosomal Impairment and Cellular Toxicity.

Authors:  Christopher J Folts; Nicole Scott-Hewitt; Christoph Pröschel; Margot Mayer-Pröschel; Mark Noble
Journal:  PLoS Biol       Date:  2016-12-15       Impact factor: 8.029

2.  α-Synuclein interacts directly but reversibly with psychosine: implications for α-synucleinopathies.

Authors:  Hazem Abdelkarim; Michael S Marshall; Giuseppe Scesa; Rachael A Smith; Emily Rue; Jeffrey Marshall; Vince Elackattu; Monika Stoskute; Yazan Issa; Marta Santos; Duc Nguyen; Zane Hauck; Richard van Breemen; Maria S Celej; Vadim Gaponenko; Ernesto R Bongarzone
Journal:  Sci Rep       Date:  2018-08-20       Impact factor: 4.379

3.  Hybrid Nanoparticles as a Novel Tool for Regulating Psychosine-Induced Neuroinflammation and Demyelination In Vitro and Ex vivo.

Authors:  Adryana Clementino; Maria Velasco-Estevez; Francesca Buttini; Fabio Sonvico; Kumlesh K Dev
Journal:  Neurotherapeutics       Date:  2021-09-03       Impact factor: 7.620

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.